0001493152-24-033342.txt : 20240820 0001493152-24-033342.hdr.sgml : 20240820 20240820205952 ACCESSION NUMBER: 0001493152-24-033342 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240815 FILED AS OF DATE: 20240820 DATE AS OF CHANGE: 20240820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CURHAN GREGORY S CENTRAL INDEX KEY: 0001263244 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38519 FILM NUMBER: 241226975 MAIL ADDRESS: STREET 1: 600 CALIFORNIA STREET, 9TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94108 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Serina Therapeutics, Inc. CENTRAL INDEX KEY: 0001708599 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 821436829 STATE OF INCORPORATION: AL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 601 GENOME WAY STREET 2: SUITE 2001 CITY: HUNTSVILLE STATE: AL ZIP: 35806 BUSINESS PHONE: (256) 327-9630 MAIL ADDRESS: STREET 1: 601 GENOME WAY STREET 2: SUITE 2001 CITY: HUNTSVILLE STATE: AL ZIP: 35806 FORMER COMPANY: FORMER CONFORMED NAME: AgeX Therapeutics, Inc. DATE OF NAME CHANGE: 20170606 3 1 ownership.xml X0206 3 2024-08-15 1 0001708599 Serina Therapeutics, Inc. SER 0001263244 CURHAN GREGORY S 601 GENOME WAY, SUITE 2001 HUNTSVILLE AL 35806 0 1 0 0 Chief Financial Officer /s/ Gregory S. Curhan 2024-08-20